Qinglei Li Selected Research

Transforming Growth Factor-beta Type I Receptor

1/2018	A novel mouse model of testicular granulosa cell tumors.
1/2018	Glandular defects in the mouse uterus with sustained activation of TGF-beta signaling is associated with altered differentiation of endometrial stromal cells and formation of stromal compartment.
12/2017	Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
1/2017	Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
7/2016	Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis.
10/2011	Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinglei Li Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 09/2007
4	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 01/2018 - 09/2007
4	Granulosa Cell Tumor 12/2017 - 10/2010
3	Testicular Neoplasms (Testicular Cancer) 01/2018 - 09/2007
3	Carcinogenesis 12/2017 - 10/2007
3	Weight Loss (Weight Reduction) 06/2010 - 09/2007
3	Cachexia 06/2010 - 09/2007
3	Wasting Syndrome (Wasting Disease) 06/2010 - 09/2007
3	Rupture 02/2009 - 08/2004
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2017
2	Infections 06/2013 - 03/2011
1	Female Infertility 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Diverticulum 10/2011
1	Influenza in Birds (Avian Flu) 03/2011
1	Ovarian Neoplasms (Ovarian Cancer) 10/2010
1	Infertility (Sterility) 12/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2007
6	Inhibins (Inhibin)IBA 01/2018 - 09/2007
6	Transforming Growth Factor-beta Type I ReceptorIBA 01/2018 - 10/2011
4	Activins (Activin)IBA 12/2017 - 09/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 11/2016
2	TensinsIBA 01/2022 - 01/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2017
2	Cre recombinaseIBA 01/2018 - 01/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 07/2016
2	AerosolsIBA 06/2013 - 03/2011
2	GonadotropinsIBA 10/2010 - 08/2004
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	Keratin-5 (Keratin 5)IBA 01/2019
1	beta CateninIBA 01/2018
1	betaglycan (TGFBR3)IBA 12/2017
1	ChemokinesIBA 01/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2016
1	Pituitary GonadotropinsIBA 10/2010
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2010
1	LigandsIBA 09/2007
1	Activin Receptors (Activin Receptor)IBA 09/2007
1	Phosphates (Orthophosphate)IBA 09/2007
1	Immunoglobulin G (IgG)IBA 09/2007
1	Peptide Hydrolases (Proteases)FDA Link 03/2007
1	Progesterone FDA LinkGeneric 03/2007
1	Matrix Metalloproteinases (MMPs)IBA 08/2004

Therapy/Procedure

3	Therapeutics 01/2017 - 12/2008